1 Min Read
July 5 (Reuters) - Portage Biotech Inc :
* FDA clears Biohaven’s investigational new drug application for BHV 4157 and portage to hold investor conference call to provide business update Source text for Eikon: Further company coverage: )
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.